呼吸道合胞病毒（RSV）更新。
Respiratory Syncytial Virus (RSV) Update.
机构信息
Department of Pediatrics, Division of Pediatric Infectious Diseases, NYU Long Island School of Medicine and NYU Langone Hospital-Long Island, Mineola, NY 11501, USA.
Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
出版信息
Viruses. 2022 Sep 23;14(10):2110. doi: 10.3390/v14102110.
Abstract
Since the initial identification of respiratory syncytial virus (RSV) in 1956, much has been learned about the epidemiological impact and clinical manifestations of RSV infections [...].
摘要
自 1956 年首次鉴定呼吸道合胞病毒（RSV）以来，人们对 RSV 感染的流行病学影响和临床表现有了更多的了解[...]。
相似文献
1
Respiratory Syncytial Virus (RSV) Update.
Viruses. 2022 Sep 23;14(10):2110. doi: 10.3390/v14102110.
2
Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection.
Arch Argent Pediatr. 2019 Aug 1;117(4):216-223. doi: 10.5546/aap.2019.eng.216.
3
Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
Influenza Other Respir Viruses. 2019 Jul;13(4):339-353. doi: 10.1111/irv.12639. Epub 2019 Mar 19.
4
Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia.
J Med Virol. 2019 Sep;91(9):1608-1615. doi: 10.1002/jmv.25500. Epub 2019 May 29.
5
Prevalence and clinical characteristics of human respiratory syncytial virus in Chinese adults with acute respiratory tract infection.
J Med Virol. 2013 Feb;85(2):348-53. doi: 10.1002/jmv.23467. Epub 2012 Nov 28.
6
[Respiratory tract infection and respiratory syncytial virus in young infants].
Kansenshogaku Zasshi. 1995 Jan;69(1):68-72. doi: 10.11150/kansenshogakuzasshi1970.69.68.
7
Human respiratory syncytial virus in children with lower respiratory tract infections or influenza-like illness and its co-infection characteristics with viruses and atypical bacteria in Hangzhou, China.
J Clin Virol. 2015 Aug;69:1-6. doi: 10.1016/j.jcv.2015.05.015. Epub 2015 May 21.
8
Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011-2016 in southern China.
Int J Infect Dis. 2020 Jan;90:5-17. doi: 10.1016/j.ijid.2019.10.009. Epub 2019 Oct 18.
9
Molecular detection and characterization of respiratory syncytial virus B genotypes circulating in Pakistani children.
Infect Genet Evol. 2017 Jan;47:125-131. doi: 10.1016/j.meegid.2016.11.024. Epub 2016 Nov 28.
10
Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season.
PLoS One. 2013 Sep 13;8(9):e74018. doi: 10.1371/journal.pone.0074018. eCollection 2013.
引用本文的文献
1
The GDF6-FTO axis modulates the innate immune and inflammatory response to human respiratory syncytial virus.
iScience. 2024 Sep 26;27(10):111038. doi: 10.1016/j.isci.2024.111038. eCollection 2024 Oct 18.
2
Advances in nucleic acid aptamer-based detection of respiratory virus and bacteria: a mini review.
Virol J. 2024 Sep 30;21(1):237. doi: 10.1186/s12985-024-02513-9.
3
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.
BMC Infect Dis. 2024 Aug 20;24(1):844. doi: 10.1186/s12879-024-09758-3.
4
Phase 3 Study Assessing Lot-to-Lot Consistency of Respiratory Syncytial Virus Prefusion Protein F3 Vaccine and Its Immune Response, Safety, and Reactogenicity When Co-administered With Quadrivalent Influenza Vaccine.
J Infect Dis. 2025 Feb 4;231(1):e144-e153. doi: 10.1093/infdis/jiae342.
5
Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
Eur J Pediatr. 2023 Dec;182(12):5303-5313. doi: 10.1007/s00431-023-05201-y. Epub 2023 Sep 20.
6
Respiratory syncytial virus with ongoing COVID-19: is it an emerging threat?
Ann Med Surg (Lond). 2023 Jan 18;85(1):67-70. doi: 10.1097/MS9.0000000000000153. eCollection 2023 Jan.
本文引用的文献
1
Respiratory syncytial virus vaccine: where are we now and what comes next?
Expert Opin Biol Ther. 2018 Dec;18(12):1247-1256. doi: 10.1080/14712598.2018.1544239. Epub 2018 Nov 14.
2
Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.
Infect Dis Ther. 2018 Mar;7(1):87-120. doi: 10.1007/s40121-018-0188-z. Epub 2018 Feb 22.
3
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
Lancet. 2017 Sep 2;390(10098):946-958. doi: 10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7.
4
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.
Pediatrics. 2014 Aug;134(2):415-20. doi: 10.1542/peds.2014-1665.
5
Respiratory syncytial virus prevention and therapy: past, present, and future.
Pediatr Pulmonol. 2011 Apr;46(4):324-47. doi: 10.1002/ppul.21377. Epub 2010 Nov 23.
6
Risk of primary infection and reinfection with respiratory syncytial virus.
Am J Dis Child. 1986 Jun;140(6):543-6. doi: 10.1001/archpedi.1986.02140200053026.
Zotero 插件